Rare but serious risks include pancreatitis and gallbladder disease, which is why physician supervision matters throughout your treatment
Common adverse effects of Wegovy predominantly involve the gastrointestinal system and include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
Users interested in understanding the broader landscape of peptides for gut health can explore additional compounds that support intestinal repair
however, this is also a patient population that is at risk for fractures, which can be a side effect of some GLP-1s
Research also documented elevated glutathione and ascorbic acid levels in GHK-Cu treated wounds
The peptide exhibits a favorable pharmacokinetic profile with predictable absorption and distribution